US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

California Resources

43.68

-0.1200-0.27%

Volume:218.55K

Turnover:9.58M

Market Cap:3.90B

PE:7.59

High:44.10

Open:43.54

Low:43.54

Close:43.80

Loading ...

Overview Company News Filings

Truist Cuts Price Target on California Resources to $60 From $75, Keeps Buy Rating

MT Newswires Live

Diamondback Energy (FANG) Surpasses Q1 Earnings and Revenue Estimates

What Is a Retirement Advisor and Why Do You Need One?

Permian Resources (PR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

California Resources Corporation (CRC) Earnings Expected to Grow: Should You Buy?

Exact Sciences to Highlight Cologuard® Test Adherence and Predicted Preference Data at Digestive Disease Week (DDW) 2025

Merck Breaks Ground on New $1 Billion Biologics Center of Excellence in Wilmington, Delaware

Purple Biotech Reports Positive NT219 Data at AACR for Colorectal and Head and Neck Cancers

Mainz Biomed Provides First Quarter 2025 Corporate Update and Path to FDA Premarket Approval

KEYTRUDA® (pembrolizumab) as Perioperative Treatment With Standard of Care (SOC) Adjuvant Therapy Significantly Improved Event-Free Survival Compared to SOC Alone in Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025

Guardant Health, Pfizer Collaborate To Develop New Cancer Therapies Using Liquid Biopsy Platform

Adagene Announces Upcoming Poster Presentation on Masked Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) at American Society of Clinical Oncology (ASCO) Annual Meeting

Natera To Present Data from 8 Studies at 2025 AACR Annual Meeting

Exact Sciences Launches the Oncodetect™ Molecular Residual Disease Test

Sun Frontier to Absorb Leasing Subsidiary CRC Japan in June

MT Newswires Live

Leap Therapeutics to Host Virtual KOL Event to Discuss Sirexatamab (DKN-01) in Second-line Patients with Advanced Microsatellite Stable Colorectal Cancer

California Resources Is Maintained at Outperform by RBC Capital

RBC Cuts Price Target on California Resources to $60 From $68, Keeps Outperform Rating

MT Newswires Live

Is California Resources (NYSE:CRC) Using Too Much Debt?

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CRC/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CRC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CRC\",,,,,undefined,":{"symbol":"CRC","market":"US","secType":"STK","nameCN":"California Resources","latestPrice":43.68,"timestamp":1747240084470,"preClose":43.8,"halted":0,"volume":218552,"delay":0,"floatShares":88249300,"shares":89175034,"eps":5.757791,"marketStatus":"Trading","change":-0.12,"latestTime":"05-14 12:28:06 EDT","open":43.535,"high":44.095,"low":43.535,"amount":9584308.597152,"amplitude":0.012785,"askPrice":43.7,"askSize":24,"bidPrice":43.64,"bidSize":112,"shortable":3,"etf":0,"ttmEps":5.757791,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1747252800000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1415854800000,"exchange":"NYSE","adjPreClose":43.8,"dividendRate":0.035024,"preHourTrading":{"tag":"盘前","latestPrice":44.3,"preClose":43.8,"latestTime":"08:56 EDT","volume":12,"amount":531.12,"timestamp":1747227397364},"postHourTrading":{"tag":"盘后","latestPrice":43.8,"preClose":43.8,"latestTime":"16:05 EDT","volume":18021,"amount":789319.8,"timestamp":1747166712445},"volumeRatio":0.395625,"impliedVol":0.4046,"impliedVolPercentile":0.568},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CRC\",,,,,undefined,":{"symbol":"CRC","floatShares":88249300,"roa":"10.26%","roe":"17.86%","lyrEps":4.741488,"volumeRatio":0.395625,"shares":89175034,"dividePrice":1.529832,"high":44.095,"amplitude":0.012785,"preClose":43.8,"low":43.535,"week52Low":30.97,"pbRate":"1.11","psRate":"1.18","week52High":60.41,"institutionHeld":0,"latestPrice":43.68,"committee":0.647059,"eps":5.757791,"divideRate":0.035024,"volume":218552,"delay":0,"ttmEps":5.757791,"open":43.535,"prevYearClose":51.89,"prevWeekClose":40.58,"prevMonthClose":34.51,"prevQuarterClose":43.97,"fiveDayClose":38.47,"twentyDayClose":34.42,"sixtyDayClose":48.24},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CRC\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2533557663","title":"Truist Cuts Price Target on California Resources to $60 From $75, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2533557663","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533557663?lang=en_us&edition=fundamental","pubTime":"2025-05-07 02:06","pubTimestamp":1746554808,"startTime":"0","endTime":"0","summary":"California Resources (CRC) has an average rating of buy and mean price target of $61.67, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CRC"],"gpt_icon":0},{"id":"2533562463","title":"Diamondback Energy (FANG) Surpasses Q1 Earnings and Revenue Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2533562463","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533562463?lang=en_us&edition=fundamental","pubTime":"2025-05-06 05:15","pubTimestamp":1746479708,"startTime":"0","endTime":"0","summary":"Diamondback Energy  came out with quarterly earnings of $4.54 per share, beating the Zacks Consensus Estimate of $4.09 per share. This compares to earnings of $4.50 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 11%. A quarter ago, it was expected that this energy exploration and production company would post earnings of $3.26 per share when it actually produced earnings of $3.64, delivering a surprise of 11.66%.Over the last four quarters, the company has surpassed consensus EPS estimates three times.Diamondback , which belongs to the Zacks Oil and Gas - Exploration and Production - United States industry, posted revenues of $4.05 billion for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 8.09%. This compares to year-ago revenues of $2.23 billion. The company has topped consensus revenue estimates four times over the last four quarters.Investors should be mindful of the fact th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/diamondback-energy-fang-surpasses-q1-211508859.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TTTN","FANG","CRC"],"gpt_icon":0},{"id":"2532897075","title":"What Is a Retirement Advisor and Why Do You Need One?","url":"https://stock-news.laohu8.com/highlight/detail?id=2532897075","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532897075?lang=en_us&edition=fundamental","pubTime":"2025-05-01 19:15","pubTimestamp":1746098100,"startTime":"0","endTime":"0","summary":"Retirement advisors are financial advisors who have trained to work as retirement specialists.If you've always wanted to understand the pros and cons of long-term care insurance, a retirement advisor can help.How do I plan for inflation?Inflation is part of life, and a retirement advisor can help you plan for it.How much income will I have?Everyone can use tax-reduction strategies, and a retirement advisor is well-equipped to help you come up with an approach that will result in the lowest amount of taxes paid.What are the pros and cons of a reverse mortgage?If you've ever been curious about how reverse mortgages work, a retirement advisor can walk you through the process.Finding a legit retirement advisorAs you near retirement, it's a retirement advisor who can best serve your needs. The caveat is this: The only retirement advisor you can count on to look out for your best interest is a fiduciary. A fiduciary is someone legally or ethically bound to act in your best interest. In other","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/retirement/2025/05/01/what-is-a-retirement-advisor-and-why-do-you-need/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["LU0266512127.USD","BK4213","CRC","LU0456854461.SGD"],"gpt_icon":0},{"id":"2532063136","title":"Permian Resources (PR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release","url":"https://stock-news.laohu8.com/highlight/detail?id=2532063136","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532063136?lang=en_us&edition=fundamental","pubTime":"2025-04-30 22:01","pubTimestamp":1746021677,"startTime":"0","endTime":"0","summary":"Wall Street expects a year-over-year increase in earnings on higher revenues when Permian Resources  reports results for the quarter ended March 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on May 7, 2025, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.This company is expected to post quarterly earnings of $0.43 per share in its upcoming report, which represents a year-over-year change of +2.4%.Revenues are expected to be $1.39","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/permian-resources-pr-earnings-expected-140117473.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PR","CRC"],"gpt_icon":0},{"id":"2531765613","title":"California Resources Corporation (CRC) Earnings Expected to Grow: Should You Buy?","url":"https://stock-news.laohu8.com/highlight/detail?id=2531765613","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531765613?lang=en_us&edition=fundamental","pubTime":"2025-04-29 22:01","pubTimestamp":1745935273,"startTime":"0","endTime":"0","summary":"California Resources Corporation  is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on May 6. On the other hand, if they miss, the stock may move lower.While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.This company is expected to post quarterly earnings of $0.83 per share in its upcoming report, which represents a year-over-year change of +10.7%.Please note ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/california-resources-corporation-crc-earnings-140113447.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TALO","CRC"],"gpt_icon":0},{"id":"2531894782","title":"Exact Sciences to Highlight Cologuard® Test Adherence and Predicted Preference Data at Digestive Disease Week (DDW) 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2531894782","media":"Business Wire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531894782?lang=en_us&edition=fundamental","pubTime":"2025-04-29 18:59","pubTimestamp":1745924340,"startTime":"0","endTime":"0","summary":"Robust research and data from multiple abstracts predict the Cologuard test as the top choice for screening average-risk adults 45 and older, and confirms adoption across diverse demographics. \"Exact Sciences is proud to share our latest research at DDW 2025, highlighting the effectiveness and strong predicted preference for Cologuard, reinforcing our continued leadership in CRC screening,\" said Paul Limburg, MD, MPH, AGAF, chief medical officer for Screening, Exact Sciences. \"Our extensive real-world data support Cologuard as an effective screening approach for all average-risk adults ages 45 and over, across multiple demographics and patient groups. Cologuard can help address colonoscopy screening capacity constraints and improve CRC detection and prevention.\"","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exact-sciences-highlight-cologuard-test-105900275.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CRC","BK4585","EXAS","LU2324357040.USD","BK4548","BK4588","LU1861558580.USD","LU0266013472.USD","BK4213","BK4139","LU1861559042.SGD","LU0456854461.SGD","LU0266512127.USD"],"gpt_icon":0},{"id":"2531869477","title":"Merck Breaks Ground on New $1 Billion Biologics Center of Excellence in Wilmington, Delaware","url":"https://stock-news.laohu8.com/highlight/detail?id=2531869477","media":"Business Wire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531869477?lang=en_us&edition=fundamental","pubTime":"2025-04-29 18:45","pubTimestamp":1745923500,"startTime":"0","endTime":"0","summary":"Merck Wilmington Biotech will serve as a launch and commercial production facility and the future U.S. home for KEYTRUDA. RAHWAY, N.J., April 29, 2025----Merck , known as MSD outside of the United States and Canada, announced today the start of construction for a $1 billion, 470,000-square-foot state-of-the-art biologics center of excellence in Wilmington, Delaware.A cornerstone of Merck’s continued commitment to investing in American innovation and infrastructure, Merck Wilmington Biotech will comprise laboratory, manufacturing and warehouse capabilities to enable the launch and commercial production of next-generation biologics and therapies including potent antibody-drug conjugates , reinforcing Merck’s focus on expanding and diversifying its pipeline.With proximity to Delaware and Pennsylvania universities, Merck Wilmington Biotech will also attract talented students and professionals, supporting community growth and development. The site’s proximity to Merck’s existing facilities ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/merck-breaks-ground-1-billion-104500898.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B2B36J28.USD","BK4135","BK4588","LU1585245621.USD","LU1035773651.USD","RCC","BCG","ALT","LU0861579265.USD","LU1974910355.USD","LU0965509010.AUD","IE00B4R5TH58.HKD","LU1066053197.SGD","LU2324357040.USD","LU0965508806.USD","HSCT","BK4161","LU0211331839.USD","LU0122379950.USD","LU0208291251.USD","LU1069347547.HKD","LU1291159041.SGD","LU2468319806.SGD","DM","BK4559","LU2361045086.USD","BK4516","LU1066051498.USD","MRK","SG9999015341.SGD","CRT","LU1023059063.AUD","BK4585","SG9999001440.SGD","LU0265550946.USD","CRC","LU1066051811.HKD","LU2023250504.SGD","BTC","SG9999002224.SGD","LU0320765646.SGD","IE00BJT1NW94.SGD","HCC","LU1116320737.USD","LU1116320901.HKD","LU0965509283.SGD","CPS","LU1929549753.HKD","BK4533","LU1983299246.USD"],"gpt_icon":0},{"id":"2530027654","title":"Purple Biotech Reports Positive NT219 Data at AACR for Colorectal and Head and Neck Cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2530027654","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530027654?lang=en_us&edition=fundamental","pubTime":"2025-04-28 20:28","pubTimestamp":1745843280,"startTime":"0","endTime":"0","summary":"Activated b-catenin or loss of its negative regulator adenomatous polyposis coli  is a potential biomarker for NT219 in the treatment of colorectal cancer. NT219’s mechanism of action informs how it can restore efficacy of immunotherapies and expand the patient population that can benefit from immunotherapies. REHOVOT, Israel, April 28, 2025  -- Purple Biotech Ltd.  , a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance, announced today that two posters reporting new NT219 data being presented at the American Association for Cancer Research  Annual Meeting on Sunday and Monday, April 27-28, 2025.NT219, a novel dual inhibitor of IRS1/2 and STAT3, is being evaluated in a Phase 2 study in patients with recurrent and/or metastatic head and neck squamous cell cancer  in combination with pembrolizumab  and in combination with cetuximab .“These biomarker and mechanism data are important guides for study design, patient sel","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/purple-biotech-reports-positive-nt219-122800847.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0266512127.USD","PPBT","BK4213","LU2236285917.USD","LU2237443382.USD","LU2237443978.SGD","LU0157215616.USD","LU1366192091.USD","APC","CRC","LU2456880835.USD","LU2237443622.USD","LU2420271590.USD","LU1496350171.SGD","PDX","BK4007","LU2417539215.USD","LU1366333091.USD","LU0077335932.USD","LU0456854461.SGD","LU2237443549.SGD"],"gpt_icon":0},{"id":"2530740278","title":"Mainz Biomed Provides First Quarter 2025 Corporate Update and Path to FDA Premarket Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2530740278","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530740278?lang=en_us&edition=fundamental","pubTime":"2025-04-28 20:01","pubTimestamp":1745841660,"startTime":"0","endTime":"0","summary":"BERKELEY, Calif., April 28, 2025  -- Mainz Biomed N.V.  , a molecular genetics diagnostic company specializing in the early detection of cancer, today reviewed its major accomplishments of the first quarter of 2025, and provided an outlook on its path to FDA premarket approval.Path to FDA premarket approval: The Company enrolled the first patient into its feasibility study eAArly DETECT 2, which evaluates the Mainz Biomed’s next-generation colorectal cancer  test, integrating a portfolio of proprietary mRNA biomarkers, an AI-developed algorithm, and a FIT test. The study is expected to include a population of approximately 2,000 average-risk patients to validate the industry-leading results of previous feasibility studies and support the transition of CRC screening to prevention. The inclusion of the first patient keeps the Company on schedule to report top-line results by the end of 2025.“I’m extremely pleased with the progress achieved during the first quarter of 2025 as we execute o","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/mainz-biomed-provides-first-quarter-120100223.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CRC","BK4213","BK4139","MYNZ","LU0456854461.SGD","LU0266512127.USD"],"gpt_icon":0},{"id":"2530548354","title":"KEYTRUDA® (pembrolizumab) as Perioperative Treatment With Standard of Care (SOC) Adjuvant Therapy Significantly Improved Event-Free Survival Compared to SOC Alone in Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2530548354","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530548354?lang=en_us&edition=fundamental","pubTime":"2025-04-28 00:00","pubTimestamp":1745769600,"startTime":"0","endTime":"0","summary":"KEYNOTE-689 marks the first positive trial in more than two decades for patients with resected locally advanced head and neck squamous cell carcinoma . Results to be presented at American Association for Cancer Research  Annual Meeting 2025 during a Plenary Session and included in official meeting press program. \"As the first positive trial in over two decades for patients with resectable, locally advanced head and neck squamous cell carcinoma, the presentation of these landmark results marks an important moment for these patients and those who care for them,\" said Dr. Ravindra Uppaluri, the study’s co-principal investigator, director of Head and Neck Surgical Oncology, Brigham and Women’s Hospital and Dana-Farber","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/keytruda-pembrolizumab-perioperative-treatment-standard-160000135.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0054578231.USD","CRC","BK4533","LU0208291251.USD","RCC","LU1037948541.HKD","BK4135","LU0320765646.SGD","LU2361044865.SGD","IE00B7SZL793.SGD","LU1162221912.USD","BTC","SMP","ON","SOC","SG9999015358.SGD","LU0320765489.SGD","LU2023250843.SGD","MRK","LU2361044949.HKD","LU0265550946.USD","CPS","OS","HCC","IE00BLSP4452.SGD","LU1854103824.USD","IE0009355771.USD","HSCT","LU1430594728.SGD","AEIS","LU1934455194.USD","IE00BLSP4239.USD","LU2106854487.HKD","LU0289739699.SGD","LU2298322129.HKD","ITT","LU1066051225.USD","SGXZ57979304.SGD","DM","ALT","IE00BZ199S13.USD","CRT","LU0861579265.USD","BK4161","BK4097","SG9999014567.USD","LU1861220033.SGD","BK4605","SG9999001440.SGD","BCG"],"gpt_icon":0},{"id":"2530616358","title":"Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2530616358","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530616358?lang=en_us&edition=fundamental","pubTime":"2025-04-26 01:00","pubTimestamp":1745600400,"startTime":"0","endTime":"0","summary":"BDC-3042 was well tolerated up to 10 mg/kg q2w with no dose-limiting toxicities and no drug-related serious adverse events. BDC-3042 showed biological activity, with clear dose-dependent increases in proinflammatory cytokines and chemokines. BDC-3042 showed signs of anti-tumor activity, including an unconfirmed partial response, stable disease ≥ 12 weeks in 3/3 non-small cell lung cancer patients and in 2/3 patients at the highest dose. Bolt is running a partnering process to advance development of BDC-3042. REDWOOD CITY, Calif., April 25, 2025  -- Bolt Biotherapeutics , a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today announced results from its Phase 1 dose-escalation clinical study of BDC-3042 at the American Association for Cancer Research  Annual Meeting, taking place April 25-30, 2025, in Chicago, Illinois.“We are excited about the potential of BDC-3042 to help patients with cancer. This initial dose-escalation study de","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bolt-biotherapeutics-presents-results-phase-170000479.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4107","LU0456854461.SGD","BK4148","BK4213","BK4585","BOLT","BK4181","CRC","BK4218","BK4588","IHC","BK4139","L","BK4162","LU0266512127.USD","BDC","LU0053666078.USD","PK"],"gpt_icon":0},{"id":"2530964139","title":"Guardant Health, Pfizer Collaborate To Develop New Cancer Therapies Using Liquid Biopsy Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2530964139","media":"Benzinga","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530964139?lang=en_us&edition=fundamental","pubTime":"2025-04-25 03:36","pubTimestamp":1745523394,"startTime":"0","endTime":"0","summary":"Guardant Health, Inc. on Thursday announced a strategic collaboration with Pfizer, Inc.  to support the development and commercialization of Pfizer’s oncology portfolio using the Guardant Infinity smart liquid biopsy platform.Under the multi-year collaboration agreement, Guardant and Pfizer aim to:. Utilize Guardant’s portfolio of liquid biopsy tests in Pfizer’s global clinical studies.Evaluate the clinical utility of  circulating tumor DNA  level as a surrogate endpoint to monitor therapy response and  related blood-based epigenomic analyses.Also Read: Medicare To Reimburse Guardant Health’s Shield Colorectal Cancer Test, Analyst Expects $10M In Revenue. The collaboration will also allow Pfizer to access Guardant’s liquid biopsy tests in China for its global clinical trials, which include China cohorts.Guardant Reveal, which runs on Guardant’s Smart Liquid Biopsy platform, is a blood test that uses epigenomic  analysis to detect circulating tumor DNA , a marker of minimal residual dis","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/guardant-health-pfizer-collaborate-develop-193634667.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CRC","LU0289739699.SGD","SG9999001176.SGD","LU0306806265.USD","BK4581","GH","LU0868494617.USD","IE00BLSP4239.USD","BK4007","BK4568","SG9999003800.SGD","BK4550","SG9999001176.USD","BK4599","LU0170899867.USD","SG9999002232.USD","LU0456854461.SGD","LU0321505868.SGD","LU1066053197.SGD","LU0234572021.USD","LU0321505439.SGD","BK4535","LU0266512127.USD","SGXZ57979304.SGD","LU0985481810.HKD","LU1894683264.USD","IE00B19Z3B42.SGD","SG9999011175.SGD","LU0225284248.USD","BK4196","LU0225771236.USD","BK4585","BK4588","LU1883839398.USD","LU1894683348.USD","BK4213","LU1057294990.SGD","BK4534","PFE","BK4533","IE00BBT3K403.USD","BK4551","IE00BLSP4452.SGD","LU1066051498.USD","LU0456855351.SGD","LU1023059063.AUD","LU0122379950.USD","SG9999002224.SGD","IE000M9KFDE8.USD","IE0002270589.USD"],"gpt_icon":1},{"id":"2529803206","title":"Adagene Announces Upcoming Poster Presentation on Masked Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) at American Society of Clinical Oncology (ASCO) Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2529803206","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529803206?lang=en_us&edition=fundamental","pubTime":"2025-04-23 22:05","pubTimestamp":1745417100,"startTime":"0","endTime":"0","summary":"SAN DIEGO and SUZHOU, China, April 23, 2025  -- Adagene Inc.  , a company transforming the discovery and development of novel antibody-based therapies, today announced a poster presentation at ASCO 2025 in Chicago, IL, May 30 - June 3.Abstract Title:Safety and Efficacy of ADG126  in Combination with Pembrolizumab: Updated Results of Phase 1b/2 Study in Advanced MSS CRC. Poster will be made available on the Publications page of the company’s websitehere.Powered by its proprietaryDynamic Precision Library platform, composed of NEObody, SAFEbody, and POWERbody technologies, Adagene’s highly differentiated pipeline features novel immunotherapy programs. The company’s SAFEbody technology is designed to address safety and tolerability challenges associated with many antibody therapeutics by using precision masking technology to shield the binding domain of the biologic therapy. Through activation in the tumor microenvironment, this allows for tumor-specific targeting of antibodies, while min","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adagene-announces-upcoming-poster-presentation-140500747.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0456854461.SGD","LU0266512127.USD","ADAG","BK4213","BK4107","BK4117","BK4113","CRC","MSS","BK4139","AFG"],"gpt_icon":0},{"id":"2529557720","title":"Natera To Present Data from 8 Studies at 2025 AACR Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2529557720","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529557720?lang=en_us&edition=fundamental","pubTime":"2025-04-23 04:05","pubTimestamp":1745352300,"startTime":"0","endTime":"0","summary":"Data spans immunotherapy  response prediction and genomic landscaping in colorectal cancer , breast cancer, and gynecological cancers. AUSTIN, Texas, April 22, 2025----Natera, Inc. , a global leader in cell-free DNA and genetic testing, today announced that data from 8 studies will be shared at the American Association of Cancer Research  Annual Meeting that will take place April 25 – 30, 2025 in Chicago, IL.An oral presentation titled \"Large-scale Genomic Profiling of Colorectal Cancer\" from an exploratory analysis examining the characteristics of the mutational landscape of CRC and patterns across clinical and molecular subgroups. The study was performed using Natera’s proprietary real-world database  that comprises de-identified clinical and genomic data from over 73,000 patients who underwent commercial Signatera testing.Natera is a global leader in cell-free DNA and genetic testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testin","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/natera-present-data-8-studies-200500535.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2065731478.USD","LU0012050646.USD","CLIA","BK4213","LU0053671581.USD","LU0456854461.SGD","LU2065169927.USD","LU1988902786.USD","LU2065170008.USD","LU1064131342.USD","LU2065171311.SGD","CRC","LU0963586101.USD","LU2065171402.SGD","BK4139","NTRA","LU0106261612.USD","LU0266512127.USD","LU2324357040.USD","LU2264538146.SGD"],"gpt_icon":0},{"id":"2529304810","title":"Exact Sciences Launches the Oncodetect™ Molecular Residual Disease Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2529304810","media":"Business Wire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529304810?lang=en_us&edition=fundamental","pubTime":"2025-04-22 18:00","pubTimestamp":1745316000,"startTime":"0","endTime":"0","summary":"Introducing the Oncodetect test from Exact Sciences Corp.The new, highly sensitive, tumor-informed test detects up to 200 ctDNA* variants, identifying signs of colorectal cancer  recurrence up to two years earlier than imaging—making it one of the most comprehensive MRD tests available1,2. The Oncodetect test is available for order across multiple solid tumors. The Oncodetect test delivers clear \"Detected\" or \"Not Detected\" results, accompanied by quantitative data to help support adjuvant therapy decisions, evaluate treatment response, and monitor cancer recurrence. Notably, patients who test positive for ctDNA with the Oncodetect test during surveillance are 50 times more likely to experience cancer recurrence than those with negative results1. Highly sensitive and personalized, the test tracks up to 200 tumor-specific variants and identifies even trace amounts of ctDNA—down to 1 ctDNA molecule in 20,000 cfDNA molecules. This sensitivity enables earlier detection of CRC recurrence co","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exact-sciences-launches-oncodetect-molecular-100000445.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4548","LU0456854461.SGD","LU0266013472.USD","LU0266512127.USD","CRC","LU2324357040.USD","BK4213","EXAS","LU1861558580.USD","BK4588","BK4585","LU1861559042.SGD","BK4139"],"gpt_icon":0},{"id":"2527456474","title":"Sun Frontier to Absorb Leasing Subsidiary CRC Japan in June","url":"https://stock-news.laohu8.com/highlight/detail?id=2527456474","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527456474?lang=en_us&edition=fundamental","pubTime":"2025-04-16 07:15","pubTimestamp":1744758937,"startTime":"0","endTime":"0","summary":"Sun Frontier Fudousan  will merge with its wholly owned unit CRC Japan on June 1 in an absorption-type transaction aimed at integrating a leased property into its replanning business, according to a Tuesday filing on the Tokyo Stock Exchange.The move, approved by the board on April 15, involves no new share issuance or cash consideration. CRC Japan, which owns a single building, will be dissolved.Price : $1892.00, Change: $-2.0, Percent Change: -0.11%","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0456854461.SGD","BK6039","BK6520","BK4213","JPY","NEX.SI","CRC","FTR","LU0266512127.USD"],"gpt_icon":0},{"id":"2527492277","title":"Leap Therapeutics to Host Virtual KOL Event to Discuss Sirexatamab (DKN-01) in Second-line Patients with Advanced Microsatellite Stable Colorectal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2527492277","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527492277?lang=en_us&edition=fundamental","pubTime":"2025-04-15 19:00","pubTimestamp":1744714800,"startTime":"0","endTime":"0","summary":"Virtual KOL Event on Wednesday, April 23, 2025, at 2:30 p.m. ET. CAMBRIDGE, Mass., April 15, 2025 /PRNewswire/ --Leap Therapeutics, Inc. , a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced it will host a virtual key opinion leader  event featuring Zev A. Wainberg, MD, Professor of Medicine at University of California, Los Angeles  and co-director of the UCLA GI Oncology Program, on Wednesday, April 23, 2025 at 2:30 p.m. ET. To register, please click here.Dr. Wainberg will connect with Leap's Chief Medical Officer, Cynthia Sirard, MD, to discuss the unmet need and how sirexatamab  may improve upon the current treatment landscape for previously treated patients with advanced microsatellite stable  colorectal cancer .The event will focus on reviewing the positive data from Part B of the Phase 2 DeFianCe study of sirexatamab in second-line patients with advanced MSS CRC. Sirexatamab, Leap's most advanced clinical program, is a humanize","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/leap-therapeutics-host-virtual-kol-110000836.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/leap-therapeutics-host-virtual-kol-110000836.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","BK4213","IE00B19Z4B17.USD","BK4007","BK4585","LPTX","BK4505","BK4181","BK4218","MSS","BK4157","LU0456854461.SGD","BK4588","IE00B66KJ199.SGD","AEIS","BK4113","CRC","BK4563","IE0031619046.USD","KOL","IE00B7SZL793.SGD","HST","LU0266512127.USD","LENZ"],"gpt_icon":0},{"id":"2526269124","title":"California Resources Is Maintained at Outperform by RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2526269124","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526269124?lang=en_us&edition=fundamental","pubTime":"2025-04-11 23:09","pubTimestamp":1744384140,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CRC/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 11, 2025 11:09 ET (15:09 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRC"],"gpt_icon":0},{"id":"2526652836","title":"RBC Cuts Price Target on California Resources to $60 From $68, Keeps Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2526652836","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526652836?lang=en_us&edition=fundamental","pubTime":"2025-04-11 18:58","pubTimestamp":1744369091,"startTime":"0","endTime":"0","summary":"California Resources (CRC) has an average rating of buy and mean price target of $61.67, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CRC"],"gpt_icon":0},{"id":"2526971667","title":"Is California Resources (NYSE:CRC) Using Too Much Debt?","url":"https://stock-news.laohu8.com/highlight/detail?id=2526971667","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526971667?lang=en_us&edition=fundamental","pubTime":"2025-04-11 18:46","pubTimestamp":1744368404,"startTime":"0","endTime":"0","summary":"Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/1032000-choice1-main-header/1585186548616","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/1032000-choice1-main-header/1585186548616"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/energy/nyse-crc/california-resources/news/is-california-resources-nysecrc-using-too-much-debt-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0456854461.SGD","EBIT","BK4213","CRC","LU0266512127.USD","NYSE"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CRC\",params:#limit:5,,,undefined,":[{"date":"2025-05-30","symbol":"CRC","amount":0.3875,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-30","defaultRemindTime":1748611800000,"name":"加州资源","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-13","payableDate":"2025-05-30","currency":"USD","dateTimestamp":1748577600000,"payDate":"2025-06-13"},{"date":"2025-05-06","symbol":"CRC","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":0.88,"defaultRemindTime":1746561600000,"name":null,"time":"Post Market","dateTimestamp":1746504000000,"actualEps":null},{"date":"2025-03-10","symbol":"CRC","amount":0.3875,"announcedDate":"2025-03-03","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-10","defaultRemindTime":1741613400000,"name":"加州资源","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-21","payableDate":"2025-03-10","currency":"USD","dateTimestamp":1741579200000,"payDate":"2025-03-21"},{"market":"US","date":"2025-03-03","symbol":"CRC","fiscalQuarterEnding":"2024/12","expectedEps":0.96,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740978000000,"reportTimeType":"pre","actualEps":0.91},{"date":"2024-12-02","symbol":"CRC","amount":0.3875,"announcedDate":"2024-11-05","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-02","defaultRemindTime":1733149800000,"name":"加州资源","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-16","payableDate":"2024-12-02","currency":"USD","dateTimestamp":1733115600000,"payDate":"2024-12-16"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CRC\",market:\"US\",,,undefined,":[{"executeDate":"2021-11-30","recordDate":"2021-12-01","paymentDate":"2021-12-16","value":0.17,"currency":"USD"},{"executeDate":"2022-03-04","recordDate":"2022-03-07","paymentDate":"2022-03-16","value":0.17,"currency":"USD"},{"executeDate":"2022-05-31","recordDate":"2022-06-01","paymentDate":"2022-06-16","value":0.17,"currency":"USD"},{"executeDate":"2022-08-31","recordDate":"2022-09-01","paymentDate":"2022-09-16","value":0.17,"currency":"USD"},{"executeDate":"2022-11-30","recordDate":"2022-12-01","paymentDate":"2022-12-16","value":0.2825,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CRC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2143,"buy":0.5714,"hold":0.2143,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5714,"analysts":14,"updateTime":1744084800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CRC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CRC","date":"2025-05-13","current":7.50423,"percent":0.760976,"low":-4.759607,"twenty":0.69083,"median":3.922794,"eighty":7.887836,"high":29.507578,"avg":5.157411,"sd":6.506654,"marketCap":3759619433},"quantilePoints":[{"date":"2020-05-15","current":-2.626598,"twenty":-4.295208,"median":-0.184022,"eighty":1.393263,"marketCap":73544747},{"date":"2020-05-22","current":-2.538457,"twenty":-4.295208,"median":-0.192857,"eighty":1.375418,"marketCap":71076803},{"date":"2020-05-29","current":-2.344547,"twenty":-4.295208,"median":-0.200937,"eighty":1.357573,"marketCap":65647325},{"date":"2020-06-05","current":-3.543263,"twenty":-4.295208,"median":-0.20336,"eighty":1.341366,"marketCap":99211370},{"date":"2020-06-12","current":-2.661854,"twenty":-4.306077,"median":-0.205204,"eighty":1.323009,"marketCap":74531925},{"date":"2020-06-19","current":-2.644226,"twenty":-4.306077,"median":-0.207188,"eighty":1.282312,"marketCap":74038336},{"date":"2020-06-26","current":-0.036027,"twenty":-4.306077,"median":-0.209371,"eighty":1.269657,"marketCap":63300220},{"date":"2020-07-02","current":-0.033776,"twenty":-4.306077,"median":-0.209371,"eighty":1.250505,"marketCap":59343956},{"date":"2020-07-10","current":-0.032931,"twenty":-4.306077,"median":-0.209371,"eighty":1.226048,"marketCap":57860357},{"date":"2020-07-17","current":-0.009314,"twenty":-4.306077,"median":-0.209371,"eighty":1.210738,"marketCap":16364095},{"date":"2020-07-24","current":-0.006596,"twenty":-4.306077,"median":-0.209371,"eighty":1.196704,"marketCap":11589380},{"date":"2020-07-31","current":-0.006023,"twenty":-4.306077,"median":-0.209371,"eighty":1.180119,"marketCap":10583005},{"date":"2020-08-07","current":-0.00497,"twenty":-4.306077,"median":-0.209371,"eighty":1.169315,"marketCap":10137925},{"date":"2020-08-14","current":-0.003103,"twenty":-4.306077,"median":-0.209371,"eighty":1.155878,"marketCap":6330022},{"date":"2020-08-21","current":-0.002424,"twenty":-4.306077,"median":-0.209371,"eighty":1.137946,"marketCap":4945329},{"date":"2020-08-28","current":-0.002373,"twenty":-4.306077,"median":-0.209371,"eighty":1.121432,"marketCap":4841477},{"date":"2020-09-04","current":-0.00223,"twenty":-4.306077,"median":-0.209371,"eighty":1.109119,"marketCap":4549703},{"date":"2020-09-11","current":-0.001964,"twenty":-4.306077,"median":-0.209371,"eighty":1.099511,"marketCap":4005717},{"date":"2020-09-18","current":-0.002351,"twenty":-4.306077,"median":-0.209371,"eighty":1.086985,"marketCap":4796969},{"date":"2020-09-25","current":-0.002109,"twenty":-4.306077,"median":-0.209371,"eighty":1.080606,"marketCap":4302436},{"date":"2020-10-02","current":-0.002082,"twenty":-4.306077,"median":-0.209371,"eighty":1.069124,"marketCap":4248038},{"date":"2020-10-09","current":-0.001697,"twenty":-4.306077,"median":-0.209371,"eighty":1.046159,"marketCap":3461730},{"date":"2020-10-16","current":-0.001909,"twenty":-4.306077,"median":-0.209371,"eighty":1.039052,"marketCap":3894447},{"date":"2020-10-23","current":-0.001178,"twenty":-4.306077,"median":-0.209371,"eighty":1.018479,"marketCap":2403430},{"date":"2020-10-30","current":-0.547167,"twenty":-4.306077,"median":-0.210775,"eighty":1.002051,"marketCap":1116220000},{"date":"2020-11-06","current":-0.439133,"twenty":-4.306077,"median":-0.215303,"eighty":0.973809,"marketCap":949844819},{"date":"2020-11-13","current":-0.536975,"twenty":-4.306077,"median":-0.216571,"eighty":0.938992,"marketCap":1161476910},{"date":"2020-11-20","current":-0.590904,"twenty":-4.306077,"median":-0.218019,"eighty":0.914188,"marketCap":1278124520},{"date":"2020-11-27","current":-0.842442,"twenty":-4.306077,"median":-0.219356,"eighty":0.899442,"marketCap":1822202298},{"date":"2020-12-04","current":-1.030421,"twenty":-4.306077,"median":-0.22033,"eighty":0.892607,"marketCap":2228800905},{"date":"2020-12-11","current":-0.770408,"twenty":-4.306077,"median":-0.222998,"eighty":0.883681,"marketCap":1666393200},{"date":"2020-12-18","current":-0.808158,"twenty":-4.306077,"median":-0.223643,"eighty":0.862133,"marketCap":1748046466},{"date":"2020-12-24","current":-0.821255,"twenty":-4.306077,"median":-0.22525,"eighty":0.849685,"marketCap":1776375151},{"date":"2020-12-31","current":-0.908697,"twenty":-4.306077,"median":-0.227441,"eighty":0.838203,"marketCap":1965510779},{"date":"2021-01-08","current":-0.94375,"twenty":-4.306077,"median":-0.228513,"eighty":0.834376,"marketCap":2041331670},{"date":"2021-01-15","current":-0.96147,"twenty":-4.306077,"median":-0.230901,"eighty":0.834376,"marketCap":2079658713},{"date":"2021-01-22","current":-0.952225,"twenty":-4.306077,"median":-0.23285,"eighty":0.834376,"marketCap":2059661995},{"date":"2021-01-29","current":-0.889436,"twenty":-4.306077,"median":-0.235524,"eighty":0.834376,"marketCap":1923850949},{"date":"2021-02-05","current":-0.92449,"twenty":-4.306077,"median":-0.237422,"eighty":0.834376,"marketCap":1999671840},{"date":"2021-02-12","current":-0.980345,"twenty":-4.306077,"median":-0.239101,"eighty":0.834376,"marketCap":2120485347},{"date":"2021-02-19","current":-1.001531,"twenty":-4.306077,"median":-0.243277,"eighty":0.834376,"marketCap":2166311160},{"date":"2021-02-26","current":-1.012317,"twenty":-4.306077,"median":-0.244974,"eighty":0.834376,"marketCap":2189640664},{"date":"2021-03-05","current":-1.020791,"twenty":-4.307042,"median":-0.24807,"eighty":0.835141,"marketCap":2207970990},{"date":"2021-03-12","current":1.210636,"twenty":-4.307042,"median":-0.250121,"eighty":0.838203,"marketCap":2137982475},{"date":"2021-03-19","current":1.13845,"twenty":-4.307042,"median":-0.250121,"eighty":0.850388,"marketCap":2010503395},{"date":"2021-03-26","current":1.14883,"twenty":-4.306077,"median":-0.249299,"eighty":0.866271,"marketCap":2028833721},{"date":"2021-04-01","current":1.127127,"twenty":-4.306077,"median":-0.249299,"eighty":0.885408,"marketCap":1990506677},{"date":"2021-04-09","current":1.144112,"twenty":-4.307042,"median":-0.250121,"eighty":0.907117,"marketCap":2020501755},{"date":"2021-04-16","current":1.139866,"twenty":-4.307042,"median":-0.250121,"eighty":0.939757,"marketCap":2013002985},{"date":"2021-04-23","current":1.059188,"twenty":-4.307042,"median":-0.250121,"eighty":0.96943,"marketCap":1870526367},{"date":"2021-04-30","current":1.118163,"twenty":-4.307042,"median":-0.250121,"eighty":0.983134,"marketCap":1974675942},{"date":"2021-05-07","current":1.176194,"twenty":-4.307042,"median":-0.248184,"eighty":1.018359,"marketCap":2077159123},{"date":"2021-05-14","current":0.57973,"twenty":-4.307042,"median":-0.2454,"eighty":1.03654,"marketCap":2010503395},{"date":"2021-05-21","current":0.708505,"twenty":-4.307042,"median":-0.243788,"eighty":1.03654,"marketCap":2457096773},{"date":"2021-05-28","current":0.696973,"twenty":-4.307042,"median":-0.239857,"eighty":1.03654,"marketCap":2417103336},{"date":"2021-06-04","current":0.737816,"twenty":-4.307042,"median":-0.238075,"eighty":1.03654,"marketCap":2558746758},{"date":"2021-06-11","current":0.799561,"twenty":-4.307042,"median":-0.236957,"eighty":1.03654,"marketCap":2772878284},{"date":"2021-06-18","current":0.782984,"twenty":-4.307042,"median":-0.233507,"eighty":1.03654,"marketCap":2715387719},{"date":"2021-06-25","current":0.79836,"twenty":-4.307042,"median":-0.231347,"eighty":1.03654,"marketCap":2768712301},{"date":"2021-07-02","current":0.722921,"twenty":-4.307042,"median":-0.228622,"eighty":1.03654,"marketCap":2507088569},{"date":"2021-07-09","current":0.704181,"twenty":-4.307042,"median":-0.227828,"eighty":1.03654,"marketCap":2442099234},{"date":"2021-07-16","current":0.634508,"twenty":-4.307042,"median":-0.225451,"eighty":1.03654,"marketCap":2200472220},{"date":"2021-07-23","current":0.634988,"twenty":-4.307042,"median":-0.223277,"eighty":1.03654,"marketCap":2202138613},{"date":"2021-07-30","current":0.675351,"twenty":-4.307042,"median":-0.223131,"eighty":1.03654,"marketCap":2342115642},{"date":"2021-08-06","current":0.682705,"twenty":-4.307042,"median":-0.223131,"eighty":1.03654,"marketCap":2476853574},{"date":"2021-08-13","current":0.671872,"twenty":-4.307042,"median":-0.221697,"eighty":1.03654,"marketCap":2437551434},{"date":"2021-08-20","current":0.645015,"twenty":-4.307042,"median":-0.218296,"eighty":1.03654,"marketCap":2340114881},{"date":"2021-08-27","current":0.755828,"twenty":-4.307042,"median":-0.218003,"eighty":1.03654,"marketCap":2742143014},{"date":"2021-09-03","current":0.829402,"twenty":-4.307042,"median":-0.218003,"eighty":1.03654,"marketCap":3009070044},{"date":"2021-09-10","current":0.887629,"twenty":-4.307042,"median":-0.217706,"eighty":1.03654,"marketCap":3220319043},{"date":"2021-09-17","current":0.970457,"twenty":-4.307042,"median":-0.21731,"eighty":1.03654,"marketCap":3520816651},{"date":"2021-09-24","current":0.931864,"twenty":-4.307042,"median":-0.216391,"eighty":1.03654,"marketCap":3380802779},{"date":"2021-10-01","current":0.946534,"twenty":-4.307042,"median":-0.215187,"eighty":1.03654,"marketCap":3434024426},{"date":"2021-10-08","current":0.910424,"twenty":-4.306077,"median":-0.210775,"eighty":1.036368,"marketCap":3303017295},{"date":"2021-10-15","current":0.958947,"twenty":-4.306077,"median":-0.20336,"eighty":1.036368,"marketCap":3479058127},{"date":"2021-10-22","current":0.983772,"twenty":-4.306077,"median":-0.188207,"eighty":1.036368,"marketCap":3569125530},{"date":"2021-10-29","current":1.041097,"twenty":-4.303903,"median":-0.163857,"eighty":1.037057,"marketCap":3777099351},{"date":"2021-11-05","current":1.033875,"twenty":-4.303903,"median":-0.154011,"eighty":1.038157,"marketCap":3750897925},{"date":"2021-11-12","current":0.929008,"twenty":-4.303903,"median":-0.147568,"eighty":1.038157,"marketCap":3493071374},{"date":"2021-11-19","current":0.866789,"twenty":-4.303903,"median":-0.144043,"eighty":1.038157,"marketCap":3259128044},{"date":"2021-11-26","current":0.862727,"twenty":-4.303903,"median":-0.135656,"eighty":1.038157,"marketCap":3243853393},{"date":"2021-12-03","current":0.867003,"twenty":-4.303903,"median":-0.132933,"eighty":1.038157,"marketCap":3259931973},{"date":"2021-12-10","current":0.957018,"twenty":-4.303903,"median":-0.131401,"eighty":1.038157,"marketCap":3598386069},{"date":"2021-12-17","current":0.907627,"twenty":-4.303903,"median":-0.129637,"eighty":1.038157,"marketCap":3412678477},{"date":"2021-12-23","current":0.890522,"twenty":-4.303903,"median":-0.128172,"eighty":1.038157,"marketCap":3348364160},{"date":"2021-12-31","current":0.913186,"twenty":-4.301729,"median":-0.127623,"eighty":1.037925,"marketCap":3433580630},{"date":"2022-01-07","current":0.923235,"twenty":-4.299556,"median":-0.125931,"eighty":1.037693,"marketCap":3471365292},{"date":"2022-01-14","current":0.94312,"twenty":-4.297382,"median":-0.124796,"eighty":1.037461,"marketCap":3546130686},{"date":"2022-01-21","current":0.8747,"twenty":-4.297382,"median":-0.123683,"eighty":1.037461,"marketCap":3288873416},{"date":"2022-01-28","current":0.908482,"twenty":-4.297382,"median":-0.119566,"eighty":1.037461,"marketCap":3415894193},{"date":"2022-02-04","current":0.943334,"twenty":-4.297382,"median":-0.113467,"eighty":1.037461,"marketCap":3546934615},{"date":"2022-02-11","current":0.923235,"twenty":-4.297382,"median":-0.1075,"eighty":1.037461,"marketCap":3471365292},{"date":"2022-02-18","current":0.867431,"twenty":-4.297382,"median":-0.103418,"eighty":1.037461,"marketCap":3261539831},{"date":"2022-02-25","current":5.165989,"twenty":-4.297382,"median":-0.102228,"eighty":1.041064,"marketCap":3161585251},{"date":"2022-03-04","current":5.545557,"twenty":-4.297382,"median":-0.098825,"eighty":1.052583,"marketCap":3393881054},{"date":"2022-03-11","current":5.426929,"twenty":-4.297382,"median":-0.095621,"eighty":1.068156,"marketCap":3321280393},{"date":"2022-03-18","current":5.554651,"twenty":-4.297382,"median":-0.093491,"eighty":1.082113,"marketCap":3399446559},{"date":"2022-03-25","current":6.319709,"twenty":-4.297382,"median":-0.09226,"eighty":1.086639,"marketCap":3867661893},{"date":"2022-04-01","current":5.824146,"twenty":-4.297382,"median":-0.090741,"eighty":1.099785,"marketCap":3564377169},{"date":"2022-04-08","current":5.839472,"twenty":-4.297382,"median":-0.089288,"eighty":1.109119,"marketCap":3573757109},{"date":"2022-04-14","current":5.72069,"twenty":-4.297382,"median":-0.088072,"eighty":1.112087,"marketCap":3501062575},{"date":"2022-04-22","current":5.49079,"twenty":-4.297382,"median":-0.085936,"eighty":1.122881,"marketCap":3360363476},{"date":"2022-04-29","current":5.135721,"twenty":-4.297382,"median":-0.083434,"eighty":1.128826,"marketCap":3143061534},{"date":"2022-05-06","current":6.317189,"twenty":-4.297382,"median":-0.036731,"eighty":1.133261,"marketCap":3354427300},{"date":"2022-05-13","current":5.948771,"twenty":-4.297382,"median":-0.034058,"eighty":1.135997,"marketCap":3158797658},{"date":"2022-05-20","current":6.138828,"twenty":-4.297382,"median":-0.032649,"eighty":1.139111,"marketCap":3259717711},{"date":"2022-05-27","current":6.608122,"twenty":-4.297382,"median":-0.009371,"eighty":1.144584,"marketCap":3508912612},{"date":"2022-06-03","current":6.673911,"twenty":-4.297382,"median":-0.006676,"eighty":1.15065,"marketCap":3543846476},{"date":"2022-06-10","current":6.877125,"twenty":-4.297382,"median":-0.006101,"eighty":1.15921,"marketCap":3651753302},{"date":"2022-06-17","current":5.682692,"twenty":-4.297382,"median":-0.004946,"eighty":1.174147,"marketCap":3017509584},{"date":"2022-06-24","current":5.565734,"twenty":-4.299556,"median":-0.003394,"eighty":1.179463,"marketCap":2955404936},{"date":"2022-07-01","current":5.815732,"twenty":-4.299556,"median":-0.002473,"eighty":1.20687,"marketCap":3088153621},{"date":"2022-07-08","current":5.768949,"twenty":-4.299556,"median":-0.002422,"eighty":1.217882,"marketCap":3063311762},{"date":"2022-07-15","current":5.995555,"twenty":-4.299556,"median":-0.002351,"eighty":1.236563,"marketCap":3183639518},{"date":"2022-07-22","current":5.82158,"twenty":-4.299556,"median":-0.002233,"eighty":1.260937,"marketCap":3091258854},{"date":"2022-07-29","current":6.558415,"twenty":-4.299556,"median":-0.002174,"eighty":1.32151,"marketCap":3482518136},{"date":"2022-08-05","current":4.050534,"twenty":-4.299556,"median":-0.002096,"eighty":1.342826,"marketCap":3370044551},{"date":"2022-08-12","current":4.168309,"twenty":-4.299556,"median":-0.001964,"eighty":1.378712,"marketCap":3468032874},{"date":"2022-08-19","current":4.409293,"twenty":-4.299556,"median":-0.001896,"eighty":1.401773,"marketCap":3668532058},{"date":"2022-08-26","current":4.541563,"twenty":-4.299556,"median":-0.001796,"eighty":1.45064,"marketCap":3778580482},{"date":"2022-09-02","current":4.189146,"twenty":-4.299556,"median":-0.001178,"eighty":1.545904,"marketCap":3485369269},{"date":"2022-09-09","current":4.14113,"twenty":-4.299556,"median":0.57973,"eighty":1.621675,"marketCap":3445420184},{"date":"2022-09-16","current":3.922794,"twenty":-4.299556,"median":0.621294,"eighty":1.942057,"marketCap":3263764908},{"date":"2022-09-23","current":3.408211,"twenty":-4.299556,"median":0.642916,"eighty":2.736523,"marketCap":2835631313},{"date":"2022-09-30","current":3.481593,"twenty":-4.299556,"median":0.661656,"eighty":2.837464,"marketCap":2896685576},{"date":"2022-10-07","current":3.8476,"twenty":-4.299556,"median":0.671266,"eighty":2.906531,"marketCap":3201203133},{"date":"2022-10-14","current":3.623829,"twenty":-4.299556,"median":0.675351,"eighty":3.023758,"marketCap":3015025320},{"date":"2022-10-21","current":3.988023,"twenty":-4.299556,"median":0.681357,"eighty":3.122843,"marketCap":3318035364},{"date":"2022-10-28","current":3.952691,"twenty":-4.299556,"median":0.687603,"eighty":3.146065,"marketCap":3288638867},{"date":"2022-11-04","current":3.104166,"twenty":-4.299556,"median":0.696733,"eighty":3.174414,"marketCap":3585311802},{"date":"2022-11-11","current":3.033154,"twenty":-4.299556,"median":0.704181,"eighty":3.174414,"marketCap":3503293178},{"date":"2022-11-18","current":2.880016,"twenty":-4.299556,"median":0.715232,"eighty":3.174414,"marketCap":3326417998},{"date":"2022-11-25","current":2.915307,"twenty":-4.299556,"median":0.720758,"eighty":3.174414,"marketCap":3367179356},{"date":"2022-12-02","current":2.813845,"twenty":-4.299556,"median":0.737816,"eighty":3.174414,"marketCap":3249990451},{"date":"2022-12-09","current":2.542228,"twenty":-4.299556,"median":0.780821,"eighty":3.174414,"marketCap":2936273567},{"date":"2022-12-16","current":2.720575,"twenty":-4.299556,"median":0.785146,"eighty":3.174414,"marketCap":3142264003},{"date":"2022-12-23","current":2.741372,"twenty":-4.299556,"median":0.78875,"eighty":3.174414,"marketCap":3166284090},{"date":"2022-12-30","current":2.742002,"twenty":-4.299556,"median":0.793555,"eighty":3.174414,"marketCap":3167011971},{"date":"2023-01-06","current":2.651883,"twenty":-4.274667,"median":0.799561,"eighty":3.174414,"marketCap":3062924931},{"date":"2023-01-13","current":2.876234,"twenty":-4.219877,"median":0.829273,"eighty":3.174414,"marketCap":3322050709},{"date":"2023-01-20","current":2.982108,"twenty":-4.167301,"median":0.834376,"eighty":3.174414,"marketCap":3444334784},{"date":"2023-01-27","current":2.719945,"twenty":-4.084814,"median":0.845858,"eighty":3.174414,"marketCap":3141536122},{"date":"2023-02-03","current":2.569327,"twenty":-4.03426,"median":0.854679,"eighty":3.174414,"marketCap":2967572467},{"date":"2023-02-10","current":2.677721,"twenty":-4.008224,"median":0.863582,"eighty":3.174414,"marketCap":3092768068},{"date":"2023-02-17","current":2.493703,"twenty":-3.990086,"median":0.867003,"eighty":3.174414,"marketCap":2880226699},{"date":"2023-02-24","current":5.825747,"twenty":-3.906528,"median":0.87299,"eighty":3.191675,"marketCap":3052691405},{"date":"2023-03-03","current":5.999019,"twenty":-3.906528,"median":0.880046,"eighty":3.256836,"marketCap":3143485739},{"date":"2023-03-10","current":5.507855,"twenty":-3.906528,"median":0.883253,"eighty":3.347056,"marketCap":2886115972},{"date":"2023-03-17","current":4.791999,"twenty":-3.906528,"median":0.885824,"eighty":3.415786,"marketCap":2511007373},{"date":"2023-03-24","current":5.025358,"twenty":-3.906528,"median":0.893516,"eighty":3.480099,"marketCap":2633287460},{"date":"2023-03-31","current":5.223442,"twenty":-3.906126,"median":0.900969,"eighty":3.517215,"marketCap":2737083349},{"date":"2023-04-06","current":5.398461,"twenty":-3.906126,"median":0.906986,"eighty":3.537959,"marketCap":2828793414},{"date":"2023-04-14","current":5.525994,"twenty":-3.874187,"median":0.910407,"eighty":3.580043,"marketCap":2895620904},{"date":"2023-04-21","current":5.345548,"twenty":-3.063777,"median":0.913186,"eighty":3.644587,"marketCap":2801067115},{"date":"2023-04-28","current":5.331981,"twenty":-2.9157,"median":0.91789,"eighty":3.660877,"marketCap":2793957808},{"date":"2023-05-05","current":2.710499,"twenty":-2.83461,"median":0.923235,"eighty":3.676244,"marketCap":2710498650},{"date":"2023-05-12","current":2.780342,"twenty":-2.714739,"median":0.924416,"eighty":3.676244,"marketCap":2780342316},{"date":"2023-05-19","current":2.80574,"twenty":-2.651277,"median":0.929008,"eighty":3.676244,"marketCap":2805740013},{"date":"2023-05-26","current":2.804329,"twenty":-2.545508,"median":0.93136,"eighty":3.676244,"marketCap":2804329030},{"date":"2023-06-02","current":2.675224,"twenty":-2.467945,"median":0.93644,"eighty":3.676244,"marketCap":2675224071},{"date":"2023-06-09","current":2.91368,"twenty":-2.316342,"median":0.942265,"eighty":3.676244,"marketCap":2913680225},{"date":"2023-06-16","current":3.019504,"twenty":-2.192945,"median":0.944095,"eighty":3.676244,"marketCap":3019503962},{"date":"2023-06-23","current":3.033614,"twenty":-1.718042,"median":0.948848,"eighty":3.679803,"marketCap":3033613794},{"date":"2023-06-30","current":3.224802,"twenty":-1.017941,"median":0.957018,"eighty":3.683362,"marketCap":3224802012},{"date":"2023-07-07","current":3.126739,"twenty":-1.0117,"median":0.960652,"eighty":3.683362,"marketCap":3126738682},{"date":"2023-07-14","current":3.32216,"twenty":-1.004921,"median":0.967067,"eighty":3.683362,"marketCap":3322159850},{"date":"2023-07-21","current":3.467491,"twenty":-0.982348,"median":0.971585,"eighty":3.683362,"marketCap":3467491115},{"date":"2023-07-28","current":3.629754,"twenty":-0.970637,"median":0.996403,"eighty":3.683362,"marketCap":3629754179},{"date":"2023-08-04","current":3.965138,"twenty":-0.961085,"median":1.005213,"eighty":3.710729,"marketCap":3596379773},{"date":"2023-08-11","current":4.167386,"twenty":-0.952225,"median":1.01715,"eighty":3.727573,"marketCap":3779819278},{"date":"2023-08-18","current":4.15294,"twenty":-0.92449,"median":1.033875,"eighty":3.745954,"marketCap":3766716456},{"date":"2023-08-25","current":4.147618,"twenty":-0.908697,"median":1.038389,"eighty":3.807376,"marketCap":3761889101},{"date":"2023-09-01","current":4.245701,"twenty":-0.892518,"median":1.046068,"eighty":3.835822,"marketCap":3850850364},{"date":"2023-09-08","current":4.253304,"twenty":-0.869791,"median":1.057139,"eighty":3.859377,"marketCap":3857746586},{"date":"2023-09-15","current":4.409932,"twenty":-0.842442,"median":1.07614,"eighty":3.897468,"marketCap":3999808760},{"date":"2023-09-22","current":4.213006,"twenty":-0.808929,"median":1.083204,"eighty":3.922794,"marketCap":3821196610},{"date":"2023-09-29","current":4.397007,"twenty":-0.773875,"median":1.091536,"eighty":3.973528,"marketCap":3988085182},{"date":"2023-10-06","current":3.991749,"twenty":-0.70608,"median":1.106481,"eighty":3.985769,"marketCap":3620516550},{"date":"2023-10-13","current":4.141535,"twenty":-0.590904,"median":1.111225,"eighty":4.007048,"marketCap":3756372123},{"date":"2023-10-20","current":4.1978,"twenty":-0.536975,"median":1.119798,"eighty":4.025939,"marketCap":3807404166},{"date":"2023-10-27","current":4.029006,"twenty":-0.518093,"median":1.126535,"eighty":4.028558,"marketCap":3654308037},{"date":"2023-11-03","current":7.887836,"twenty":-0.278454,"median":1.132317,"eighty":4.047258,"marketCap":3620516550},{"date":"2023-11-10","current":7.576588,"twenty":-0.034677,"median":1.134676,"eighty":4.075326,"marketCap":3477654048},{"date":"2023-11-17","current":7.666287,"twenty":-0.0331,"median":1.137946,"eighty":4.100348,"marketCap":3518825959},{"date":"2023-11-24","current":7.735057,"twenty":-0.031186,"median":1.139866,"eighty":4.114893,"marketCap":3550391090},{"date":"2023-12-01","current":7.655823,"twenty":-0.007262,"median":1.146471,"eighty":4.140768,"marketCap":3514022569},{"date":"2023-12-08","current":7.343371,"twenty":-0.006175,"median":1.153272,"eighty":4.15294,"marketCap":3370607081},{"date":"2023-12-15","current":7.699177,"twenty":-0.005661,"median":1.164163,"eighty":4.166853,"marketCap":3533922326},{"date":"2023-12-21","current":8.083389,"twenty":-0.004329,"median":1.174914,"eighty":4.173165,"marketCap":3710275343},{"date":"2023-12-29","current":8.213452,"twenty":-0.002728,"median":1.179572,"eighty":4.184722,"marketCap":3769974613},{"date":"2024-01-05","current":7.787381,"twenty":-0.002424,"median":1.200531,"eighty":4.190957,"marketCap":3574408038},{"date":"2024-01-12","current":7.663298,"twenty":-0.002376,"median":1.215841,"eighty":4.213006,"marketCap":3517453562},{"date":"2024-01-19","current":7.540709,"twenty":-0.002348,"median":1.23323,"eighty":4.21852,"marketCap":3461185284},{"date":"2024-01-26","current":7.703662,"twenty":-0.00223,"median":1.25325,"eighty":4.229765,"marketCap":3535980922},{"date":"2024-02-02","current":7.107163,"twenty":-0.00217,"median":1.308157,"eighty":4.245701,"marketCap":3262187716},{"date":"2024-02-09","current":8.022094,"twenty":-0.002082,"median":1.341101,"eighty":4.269271,"marketCap":3682141204},{"date":"2024-02-16","current":8.139367,"twenty":-0.001939,"median":1.357573,"eighty":4.305767,"marketCap":3735969362},{"date":"2024-02-23","current":8.27369,"twenty":-0.001896,"median":1.390517,"eighty":4.333899,"marketCap":3797623594},{"date":"2024-03-01","current":6.407884,"twenty":-0.001842,"median":1.402185,"eighty":4.370203,"marketCap":3614046387},{"date":"2024-03-08","current":6.000098,"twenty":-0.001842,"median":1.402185,"eighty":4.398139,"marketCap":3384055319},{"date":"2024-03-15","current":6.635114,"twenty":-0.001842,"median":1.402185,"eighty":4.486299,"marketCap":3742204060},{"date":"2024-03-22","current":6.837155,"twenty":-0.001842,"median":1.402185,"eighty":4.590123,"marketCap":3856155238},{"date":"2024-03-28","current":6.696949,"twenty":-0.001842,"median":1.402185,"eighty":4.889684,"marketCap":3777079302},{"date":"2024-04-05","current":6.605511,"twenty":-0.001842,"median":1.400126,"eighty":5.026714,"marketCap":3725508039},{"date":"2024-04-12","current":6.893237,"twenty":-0.001842,"median":1.400126,"eighty":5.165989,"marketCap":3887785613},{"date":"2024-04-19","current":6.545771,"twenty":-0.001842,"median":1.400126,"eighty":5.223442,"marketCap":3691814813},{"date":"2024-04-26","current":6.737182,"twenty":-0.001842,"median":1.402185,"eighty":5.288565,"marketCap":3799770657},{"date":"2024-05-03","current":6.278771,"twenty":-0.001842,"median":1.402185,"eighty":5.337699,"marketCap":3541226726},{"date":"2024-05-10","current":13.595091,"twenty":-0.001842,"median":1.402185,"eighty":5.365367,"marketCap":3439558041},{"date":"2024-05-17","current":13.340471,"twenty":-0.001842,"median":1.402185,"eighty":5.398279,"marketCap":3375139142},{"date":"2024-05-24","current":12.657872,"twenty":-0.001842,"median":1.402185,"eighty":5.428033,"marketCap":3202441667},{"date":"2024-05-31","current":12.76893,"twenty":-0.001842,"median":1.402185,"eighty":5.474551,"marketCap":3230539272},{"date":"2024-06-07","current":12.771639,"twenty":-0.001842,"median":1.402185,"eighty":5.522366,"marketCap":3231224579},{"date":"2024-06-14","current":13.283588,"twenty":-0.001842,"median":1.400126,"eighty":5.545711,"marketCap":3360747685},{"date":"2024-06-21","current":13.440694,"twenty":-0.00185,"median":1.396694,"eighty":5.56864,"marketCap":3400495517},{"date":"2024-06-28","current":14.203543,"twenty":-0.001873,"median":1.390517,"eighty":5.588625,"marketCap":3593496288},{"date":"2024-07-05","current":18.737699,"twenty":-0.001873,"median":1.390517,"eighty":5.623622,"marketCap":4740637844},{"date":"2024-07-12","current":18.734158,"twenty":-0.001873,"median":1.390517,"eighty":5.681579,"marketCap":4739742032},{"date":"2024-07-15","current":18.199504,"twenty":-0.001873,"median":1.390517,"eighty":5.682628,"marketCap":4604474399},{"date":"2024-08-02","current":17.324936,"twenty":-0.001911,"median":1.346824,"eighty":5.705155,"marketCap":4383208801},{"date":"2024-08-09","current":26.336533,"twenty":-0.001911,"median":1.353001,"eighty":5.730738,"marketCap":4319191489},{"date":"2024-08-16","current":27.446127,"twenty":-0.001911,"median":1.366496,"eighty":5.752282,"marketCap":4501164861},{"date":"2024-08-23","current":27.935654,"twenty":-0.001911,"median":1.402185,"eighty":5.768949,"marketCap":4581447230},{"date":"2024-08-30","current":28.947342,"twenty":-0.001911,"median":1.534648,"eighty":5.815918,"marketCap":4747364128},{"date":"2024-09-06","current":26.798864,"twenty":-0.001911,"median":1.621812,"eighty":5.830215,"marketCap":4395013727},{"date":"2024-09-13","current":26.532344,"twenty":-0.001911,"median":2.339797,"eighty":5.906847,"marketCap":4351304437},{"date":"2024-09-20","current":28.69714,"twenty":-0.001911,"median":2.536241,"eighty":5.949941,"marketCap":4706330917},{"date":"2024-09-27","current":27.065384,"twenty":-0.001911,"median":2.572163,"eighty":5.993801,"marketCap":4438723018},{"date":"2024-10-04","current":29.175788,"twenty":-0.001911,"median":2.598946,"eighty":6.004674,"marketCap":4784829234},{"date":"2024-10-11","current":28.196735,"twenty":-0.001911,"median":2.632346,"eighty":6.084735,"marketCap":4624264494},{"date":"2024-10-18","current":28.457816,"twenty":-0.001911,"median":2.652829,"eighty":6.188884,"marketCap":4667081758},{"date":"2024-10-25","current":28.909268,"twenty":-0.001911,"median":2.676473,"eighty":6.29292,"marketCap":4741119943},{"date":"2024-10-31","current":28.457816,"twenty":-0.001911,"median":2.700529,"eighty":6.318197,"marketCap":4667081758},{"date":"2024-11-08","current":9.769816,"twenty":-0.001911,"median":2.720575,"eighty":6.403954,"marketCap":5187772215},{"date":"2024-11-15","current":10.08759,"twenty":-0.001911,"median":2.730028,"eighty":6.445337,"marketCap":5356510077},{"date":"2024-11-22","current":10.289652,"twenty":-0.001911,"median":2.745773,"eighty":6.495297,"marketCap":5463805348},{"date":"2024-11-29","current":10.217117,"twenty":-0.001911,"median":2.769054,"eighty":6.509101,"marketCap":5425289097},{"date":"2024-12-06","current":9.553937,"twenty":-0.001911,"median":2.793041,"eighty":6.54466,"marketCap":5073140515},{"date":"2024-12-13","current":9.540121,"twenty":-0.001911,"median":2.802213,"eighty":6.559607,"marketCap":5065804086},{"date":"2024-12-20","current":8.804405,"twenty":-0.001911,"median":2.809973,"eighty":6.611052,"marketCap":4675139252},{"date":"2024-12-27","current":8.8424,"twenty":-0.001911,"median":2.83149,"eighty":6.63564,"marketCap":4695314432},{"date":"2025-01-03","current":8.98229,"twenty":-0.001911,"median":2.859849,"eighty":6.695486,"marketCap":4769595773},{"date":"2025-01-10","current":9.056419,"twenty":-0.001912,"median":2.878125,"eighty":6.715023,"marketCap":4808958516},{"date":"2025-01-17","current":9.287002,"twenty":-0.001912,"median":2.910877,"eighty":6.768152,"marketCap":4931398273},{"date":"2025-01-24","current":9.164828,"twenty":-0.001912,"median":2.92539,"eighty":6.812937,"marketCap":4866523476},{"date":"2025-01-31","current":8.779375,"twenty":-0.001912,"median":2.958773,"eighty":6.905886,"marketCap":4661848062},{"date":"2025-02-07","current":8.251098,"twenty":-0.001912,"median":2.977067,"eighty":7.022037,"marketCap":4381333096},{"date":"2025-02-14","current":7.96545,"twenty":-0.001912,"median":3.016876,"eighty":7.290747,"marketCap":4229653994},{"date":"2025-02-21","current":8.393922,"twenty":-0.001912,"median":3.041727,"eighty":7.484796,"marketCap":4457172647},{"date":"2025-02-28","current":7.688406,"twenty":-0.001893,"median":3.115452,"eighty":7.51948,"marketCap":4082543540},{"date":"2025-03-07","current":9.891447,"twenty":-0.001794,"median":3.192349,"eighty":7.555659,"marketCap":3719184042},{"date":"2025-03-14","current":10.152193,"twenty":-0.001042,"median":3.260077,"eighty":7.584063,"marketCap":3817224529},{"date":"2025-03-21","current":10.724385,"twenty":0.607359,"median":3.33664,"eighty":7.655823,"marketCap":4032368932},{"date":"2025-03-28","current":10.680928,"twenty":0.634508,"median":3.474546,"eighty":7.696187,"marketCap":4016028850},{"date":"2025-04-04","current":9.797289,"twenty":0.645015,"median":3.602945,"eighty":7.709642,"marketCap":3683780532},{"date":"2025-04-11","current":8.073821,"twenty":0.663604,"median":3.657801,"eighty":7.734459,"marketCap":3035756810},{"date":"2025-04-17","current":8.348654,"twenty":0.671387,"median":3.719197,"eighty":7.75509,"marketCap":3139094008},{"date":"2025-04-25","current":8.524644,"twenty":0.677063,"median":3.80955,"eighty":7.787381,"marketCap":3205266074},{"date":"2025-05-02","current":8.536698,"twenty":0.682705,"median":3.875685,"eighty":7.879412,"marketCap":3209798407},{"date":"2025-05-09","current":7.246139,"twenty":0.689525,"median":3.918265,"eighty":7.887836,"marketCap":3630315634},{"date":"2025-05-13","current":7.50423,"twenty":0.69083,"median":3.922794,"eighty":7.887836,"marketCap":3759619433}],"updateTime":1747240086089}}}